100% Lab-Tested
Free Shipping on Orders $50+
Card Payments Accepted
Ethnobotany: What It Is, Why It Matters, and Where amama Stands

Ethnobotany: What It Is, Why It Matters, and Where amama Stands

by amama in Micro Educate

TL;DR — The essentials in 30 seconds:

  • Ethnobotany is the science that examines how cultures around the world use plants for food, healing, ritual, material, and spirituality — a discipline at the intersection of botany, ethnology, and pharmacology.
  • The most important ethnobotanical plants include the ayahuasca vine, iboga, kratom, peyote, kanna, blue lotus, and many more, each deeply rooted in specific cultural contexts.
  • German-language ethnobotany was decisively shaped by Christian Rätsch, Wolf-Dieter Storl, and Markus Berger — their works remain standard references to this day.
  • amama in Berlin-Neukölln is the curated German-language destination for ethnobotanical plants, extracts, seeds, and scientifically grounded reference literature.
  • You can identify reputable ethnobotanical sources by their lab tests, transparent sourcing documentation, legally compliant product range, and scientific rather than mystifying communication.

What Is Ethnobotany?

Ethnobotany is the scientific discipline that examines the relationship between humans and plants — systematically, cross-culturally, and interdisciplinarily. It does not only ask what a plant is botanically, but how different societies perceive, use, interpret, and integrate that plant into their worldviews.

The term combines the Greek ethnos (people, community) and botanike (the study of plants). It was coined in 1895 by John William Harshberger at the University of Pennsylvania to describe a method for documenting the useful plants of ancient and contemporary cultures.

Academically, ethnobotany is positioned at the intersection of:

  • Botany (identification, biology, chemistry of the plant)
  • Ethnology and anthropology (cultural contexts, rituals, social structures)
  • Pharmacology and pharmacognosy (active compounds, dosage, effects)
  • Religious studies (shamanic traditions, ceremonies, cosmology)

What distinguishes ethnobotany from mere folklore studies: it upholds scientific standards, employs field research, structured interviews, chemical analyses, and ethnographic documentation — with the goal of systematically preserving traditional human-plant relationships.

History and Pioneers

Modern ethnobotany was shaped in the 20th century by a handful of defining figures whose work continues to define the foundations of the field.

Richard Evans Schultes (1915–2001) is considered the "father of modern ethnobotany." Years of field research in the Amazon Basin earned him a professorship at Harvard and laid the scientific foundation for the study of psychoactive plants in indigenous contexts. His collaborative work with Albert Hofmann, Plants of the Gods (1979), remains a classic.

Wade Davis — Schultes' student — extended the discipline's reach to the general public, most notably through The Serpent and the Rainbow (1985) and his research into zombification in Haiti.

In the German-speaking world, three names are central:

  • Christian Rätsch (1957–2022) — ethnopharmacologist whose multi-volume Enzyklopädie der psychoaktiven Pflanzen represents the most comprehensive German-language standard work in the discipline. Rätsch combined field research with pharmacological expertise and anthropological depth.
  • Wolf-Dieter Storl — Swiss-German ethnobotanist with a focus on folklore; his popular-science books opened the subject to a broad readership, with particular focus on European plant traditions.
  • Markus Berger — German author and editor, known for practical literature on ethnobotanical and psychoactive plants; founder associated with the Nachtschatten Verlag publishing environment and editor of the Entheogen Review.

What Distinguishes Ethnobotany from Conventional Botany?

Aspect Botany Ethnobotany
Focus Plant as a biological system Plant in human use and practice
Methods Laboratory, field research, genetics Field research, interviews, analysis of tradition
Goal Understanding plants Understanding the human-plant relationship
Examples Photosynthesis, taxonomy, ecology Shamanism, traditional medicine, ritual
Practitioners Biologists, ecologists Anthropologists, ethnologists, pharmacologists
Sources of knowledge Measurable natural phenomena Also orally transmitted knowledge

Key Ethnobotanical Plants — An Overview

The table below shows a cross-section of culturally significant plants that have been intensively studied in ethnobotany. For selected plants you will find in-depth guides on amama.

Plant Cultural context Primary use Primary compound(s)
Tabernanthe iboga West Africa (Bwiti, Gabon) Initiation, healing, visionary ritual Ibogaine → Iboga Guide
Banisteriopsis caapi Amazon Ayahuasca ceremony, healing Harmala alkaloids (MAO inhibitors)
Mitragyna speciosa Southeast Asia (Thailand, Malaysia) Stimulant, analgesic, labour aid Mitragynine, 7-OH-mitragynine → Kratom Guide
Lophophora williamsii Mexico, southwestern USA (Huichol) Peyote ceremony, spiritual vision Mescaline
Sceletium tortuosum South Africa (San, Khoikhoi) Mood, endurance, social rituals Mesembrine, mesembrenone
Nicotiana rustica Amazon, Andes Rapé ceremonies, purification Nicotine (highly concentrated) → Rapé Guide
Nymphaea caerulea Ancient Egypt Relaxation, ritual, joy Nuciferine, aporphine alkaloids → Blue Lotus Guide
Salvia divinorum Mexico (Mazatec, Oaxaca) Divination, healing Salvinorin A
Cannabis sativa Eurasia, worldwide Medicine, fibre, spirituality, food THC, CBD, terpenes
Ephedra sinica China, Central Asia Traditional medicine (TCM), energy Ephedrine
Acacia confusa Asia (Taiwan, Southeast Asia) Ritual, medicinal DMT (bark)
Theobroma cacao Mesoamerica (Maya, Aztec) Ceremony, food, medicine Theobromine, phenylethylamine
Erythroxylum coca Andes (Quechua, Aymara) Endurance, ritual, medicine Cocaine alkaloids
Pausinystalia johimbe West Africa (Cameroon, Nigeria) Aphrodisiac, ritual Yohimbine
Cytisus scoparius Europe (Celtic, Germanic) Folk medicine, ritual Sparteine

Ethnobotany in Germany and Europe

The academic landscape in Germany is fragmented: there is no independent degree programme called "Ethnobotany" at German universities. The subject exists embedded within:

  • Ethnology / Social anthropology (e.g. FU Berlin, University of Heidelberg)
  • Botany with ethnomedicine connections (University of Würzburg, University of Hamburg)
  • Pharmacognosy (Humboldt-Universität zu Berlin, University of Freiburg)
  • University of Zurich and University of Vienna — somewhat more explicitly anchored in Switzerland and Austria

Institutionally, the relevant actors in Europe include:

  • ECBS (European Coalition for Psychedelic Science) — scientific networking and symposia
  • MIND Foundation (Berlin) — psychedelic research, ayahuasca in medical contexts, clinical trials
  • Nachtschatten Verlag (Solothurn) — the most important German-language specialist publisher for ethnobotany literature

The most significant event formats are consciousness conferences (e.g. Beyond Psychedelics, ECBS symposia) and informal expert circles in cities such as Berlin, Vienna, and Zurich — with Berlin playing a particular role as a hub for research, community, and specialist retail.

Ethnobotanical Retail — Where Can I Find Plants, Seeds, and Books?

amama — Berlin's Ethnobotany Home

amama is based in Berlin-Neukölln and operates as a curated ethnobotany specialist shop — with the ambition of connecting product range, education, and community. What that means in practice:

  • Curated rather than mass-market: The product range is selected according to scientific relevance, sourcing transparency, and ethnobotanical context — no impulse purchases without background knowledge.
  • Scientific standards: Every plant is accompanied by compound profiles linking to primary sources (PubChem, PubMed). amama operates a hub-and-spoke content system: pillar articles → sub-guides → compound profiles.
  • Compliance awareness: The product range is assembled in compliance with the BtMG (Narcotics Act) and NpSG (New Psychoactive Substances Act). Grey areas are communicated transparently.
  • Ethical supply chains: Where possible, direct or traceable sourcing from indigenous producer networks.
  • Four complete plant pillars: Kratom, Blue Lotus, Iboga, Rapé
  • Seven compound profiles: Mitragynine, nuciferine, apomorphine, ibogaine, muscimol, mesembrine, nicotine

COLLECTION-GRID: plant-extracts

Further Reputable Sources in the German-Speaking World

  • Indian Spirit (Netherlands, ships to Germany) — one of the largest ranges of ethnobotanical plants and accessories in Europe
  • Magic Garden Seeds (Germany) — specialist in ethnobotanical seeds, very extensive seed catalogue
  • Pharmacies — for many legal adaptogens and herbs, the cleanest and most reliable source
  • Botanical gardens and university collections — for study and identification; e.g. the Botanical Garden Berlin-Dahlem, home to one of the most significant plant collections in Europe

How Do I Identify Reputable Ethnobotanical Sources?

The field unfortunately also attracts providers who trade in mystique rather than substance. Six criteria help with assessment:

  1. Lab tests and certificates of analysis — Are ingredients and purity verified? Are CoAs (Certificates of Analysis) provided on request?
  2. Clear sourcing documentation — Where does the plant come from? Which country, which region, which tradition? Is the supply chain disclosed?
  3. Compliance awareness — Is the provider aware of the legal situation (BtMG, NpSG) and do they communicate about it transparently — rather than concealing legal grey areas?
  4. Scientific education rather than "trip marketing" — Are effects described soberly and with cited sources, or is marketing based on vague promises and spiritual superlatives?
  5. Fair supply chains to indigenous producers — Is the culture of origin respected and fairly compensated, or are traditions merely instrumentalised as a marketing vehicle?
  6. Solid, verifiable information — Are there traceable literature references, primary sources, and compound profiles? Or does it remain at the level of unsubstantiated claims?

Ethnobotany Literature — Essential Books

A short, reliable reading list for beginners and advanced readers:

Title Author Note
Enzyklopädie der psychoaktiven Pflanzen Christian Rätsch The German-language standard work par excellence — scientific, cultural, practical
Pflanzenmagie Wolf-Dieter Storl Accessible, folkloric, European focus
Plants of the Gods Richard Evans Schultes & Albert Hofmann English-language classic illustrated work, international foundation
Pharmako/Poeia Dale Pendell Literary-scientific, for advanced readers
Entheogene – Pflanzen der Götter Markus Berger (ed.) Practice-oriented, current, German-language

For beginners, the combination of Rätsch (reference work) and Storl (narrative approach) is recommended — the two complement each other in content.

Studying Ethnobotany — Is That Possible?

Honest answer: there is no dedicated degree programme called "Ethnobotany" in Germany. The subject exists institutionally only as a sub-discipline of related fields of study. Possible routes:

  • Ethnology / Social anthropology with a self-defined botanical focus (FU Berlin, LMU Munich)
  • Biology with ethnoecology modules — available at select German universities
  • Botany with pharmacognosy (University of Freiburg, University of Heidelberg)
  • University of Zurich — offers the most explicit ethnomedicine and ethnobiology modules
  • Self-directed study — for many practitioners in the field, the realistic path: Rätsch, Schultes, Storl as the foundation, supplemented by PubMed primary literature and field contacts

The absence of a German degree programme is not an argument against the field — it is an expression of an institutional gap that practice has long since outpaced.

FAQ — Frequently Asked Questions about Ethnobotany

1. What does ethnobotany mean?

Ethnobotany is the science of the relationships between humans and plants — how different cultures use plants for food, healing, ritual, craft, and spirituality.

2. Who was Christian Rätsch?

Christian Rätsch (1957–2022) was one of the most significant ethnopharmacologists in the German-speaking world. His Enzyklopädie der psychoaktiven Pflanzen (from 1998, AT Verlag) is considered the most comprehensive German-language standard work in the field.

3. Are ethnobotanical plants legal in Germany?

That depends on the plant. Many classic ethnobotanical plants are legal in Germany (e.g. blue lotus, kanna, kratom). Others are subject to the BtMG (e.g. peyote, iboga) or the NpSG. The legal situation is complex and changes — reputable providers communicate this transparently.

4. Where can I buy ethnobotanical plants in Berlin?

amama in Berlin-Neukölln is the curated destination for ethnobotanical plants, extracts, and seeds in the city — with scientific standards and a product range compliant with the BtMG and NpSG.

5. Which books should I read as a beginner?

Start with Christian Rätsch's Enzyklopädie der psychoaktiven Pflanzen as a reference work and Wolf-Dieter Storl's Pflanzenmagie for a narrative introduction. For English-language sources: Schultes & Hofmann's Plants of the Gods.

6. Are ethnobotanical plants drugs?

Not by definition. Many ethnobotanical plants have no psychoactive effect (cacao, coca tea in small quantities, many medicinal plants). Others contain psychoactive compounds. The word "Droge" in German is botanically neutral in origin — it simply refers to dried plant material. The cultural connotation is more recent.

7. What is the difference between ethnobotany and herbalism?

Herbalism (phytotherapy) focuses on medicinal applications, usually within a Western medical framework. Ethnobotany is broader: it encompasses all forms of use (food, ritual, material, medicine) and always views these within the cultural context of the respective society.

8. Can I study ethnobotany in Germany?

Not as an independent degree subject. Related paths exist through ethnology, biology, or pharmacognosy — supplemented by a systematic self-directed study of the specialist literature.

amama: Our Pillars and What We Curate

amama positions itself as a content-first ethnobotany platform: purchasing is possible, but understanding comes first. This is reflected in the hub-and-spoke structure:

Plant pillars (complete guides):

Compound profiles (active substances with PubChem links):

Mitragynine · Nuciferine · Apomorphine · Ibogaine · Muscimol · Mesembrine · Nicotine

Collections:

COLLECTION-GRID: plant-extracts

COLLECTION-GRID: rape

Current Developments 2026

Ethnobotany is currently experiencing an unusual renaissance — driven simultaneously by scientific, political, and social developments:

  • Psychedelic research: MAPS, Johns Hopkins, the MIND Foundation (Berlin), and others are conducting clinical trials with psilocybin-containing substances, ayahuasca, and MDMA. Academic medicine's interest in indigenous plant knowledge is growing.
  • Iboga and ibogaine: Stanford research (2023) demonstrated structural neuroplasticity effects of ibogaine. An executive order from the Trump administration (April 2026) designated ibogaine as worthy of investigation for veterans' PTSD and addiction treatment — an extraordinary political step.
  • Cannabis reform in Germany: The Cannabis Act (CanG, 2024) legalised private possession and cultivation — a milestone with direct implications for the ethnobotanical retail sector.
  • Ayahuasca in Europe: The MIND Foundation and European partners are bringing ayahuasca into regulated research contexts — from the shamanic setting into the clinical framework.
  • Ethics of knowledge extraction: In parallel, the critical debate over the cultural appropriation of indigenous plant knowledge is growing. Questions of fair compensation, intellectual property, and the right of indigenous communities to participate in decisions are moving to the foreground — including within specialist retail.

Updated April 2026. Education over sales. Not a medicinal product. Not a substitute for medical advice. All statements regarding legal status are provided without guarantee — verify current legislation before purchasing or using ethnobotanical plants.

amama.space — Berlin's Ethnobotany Home.

Tags: ethnobotanik
Previous Post Next Post

Related Posts

Bad Trip Prevention: The Comprehensive Set & Setting Guide for Psychoactive Experiences 2026

TL;DR — The Most Important Points in 60 Seconds A bad trip is not a punishment and not a failure — it is almost always a preventable or at least manageable experience when the right preparations are made. Studies suggest that set & setting are the strongest predictors of how a psychoactive experience unfolds — far more influential than the substance itself. What a bad trip is: A subjectively overwhelming, anxiety-laden psychoactive experience — not a clinical term, but a community expression for acutely difficult phases that are hard to navigate Why set & setting are decisive: The mental state before and during the experience, as well as the physical and social environment, together explain more variance in outcome than the substance itself, according to research (Haijen et al. 2018) Most common triggers: Incorrect dosage, unprocessed emotional material, unsafe environment, exhaustion, substance misidentification due to adulterants Immediate relief techniques: Slow breathing (box breathing), change of environment, trusted companionship, physical grounding, acceptance rather than resistance Pharmacological emergency brakes: Benzodiazepines (e.g. lorazepam) are considered the most effective trip stopper for classical psychedelics — only under medical supervision or via emergency services When to seek professional help immediately: In cases of loss of consciousness, suicidal impulses, seizures, or persistent perceptual disturbances lasting more than 24 hours → Emergency 112 Integration matters: Difficult experiences can be valuable in the long term — deliberate follow-up work (writing, conversation, professional support) transforms crises into insights ⚠️ This article is purely educational and does not constitute medical advice. In acute emergencies: Emergency 112. BZgA Drug Helpline (Germany's Federal Centre for Health Education): 0800 1 31 23 13 (free, anonymous, 24/7). What Is a Bad Trip? The term "bad trip" is not a clinical diagnosis, but an expression originating in subculture to describe psychoactive experiences that are subjectively overwhelming, anxiety-laden, or disorienting. Users report a broad spectrum: from mild discomfort to intense anxiety states to experiences of ego dissolution that can feel threatening. An important distinction — one that is receiving increasing attention in the scientific literature — is this: an experience that is acutely perceived as negative does not necessarily cause long-term harm. Studies such as Carbonaro et al. (2016) in the Journal of Psychopharmacology show that a significant proportion of people who experienced intense anxiety during a psilocybin experience nevertheless rated that experience in retrospect as one of the most meaningful of their lives. At the same time, approximately 7.6% of that group reported lasting negative effects — a clear argument for preparation and harm reduction. "Bad" therefore refers to the acute phase of the experience — not necessarily to its long-term value. This does not, however, remove the obligation to prepare: intense experiences without an adequate foundation can leave real psychological burdens. The Science Behind "Set" and "Setting" The concept of "set and setting" was significantly popularised by psychologist Timothy Leary in the 1960s, though its underlying idea is older: shamanic cultures worldwide have practised the importance of preparation, environment, and intention in the use of psychoactive plants for thousands of years. Modern research has empirically substantiated this intuition. An influential study by Studerus et al. (2011) in the Journal of Psychopharmacology identified psychological and situational factors as stronger predictors of psilocybin experiences than dose alone. Haijen et al. (2018) demonstrated in Frontiers in Pharmacology that factors such as surrender (the capacity to let go), positive expectations, and a safe setting correlated significantly with mystical and positive experiences — while resistance and fear of loss of control were associated with difficult experiences. Aspect What it means Estimated influence on experience Set (Mindset) Mental/emotional state, expectations, current life phase, personality structure, intention ~45–55% Setting (Environment) Physical environment, social surroundings, companionship, perceived safety ~25–35% Substance & Dose Pharmacological properties, dosage, quality, purity ~15–25% Note: These percentages are estimates based on the available research literature and are not absolute values — the interaction of all three factors is complex. Sources: Studerus et al., 2011, Journal of Psychopharmacology Carbonaro et al., 2016, Journal of Psychopharmacology Haijen et al., 2018, Frontiers in Pharmacology Most Common Triggers of a Bad Trip Users and harm reduction organisations such as eve-rave.net consistently report similar patterns that predispose people to difficult experiences: Incorrect dosage — "Too much too soon" is one of the most frequently reported factors. Substances like psilocybin or LSD have steep dose-response curves; small differences in quantity can qualitatively transform the experience. Without precise weighing (a precision scale with 0.01 g resolution), reliable dosing is barely possible. Substance misidentification due to adulterants — Drug-checking services such as saferparty.ch or the checkit! programme regularly document samples where substances contained compounds other than the expected active ingredient — sometimes significantly more dangerous ones. Reagent tests (Hofmann, Ehrlich, Mecke) can at least provide basic information. Unprocessed emotional material — Psychedelics often amplify and condense what is already present in one's consciousness. Unprocessed grief, active stress, relationship conflicts, or latent anxieties can become prominent. Studies suggest this is not inherently harmful — but without preparation, the confrontation can be overwhelming. Unsafe or overstimulating setting — Festivals, parties, unfamiliar apartments, loud environments: sensory overload combined with heightened sensory sensitivity is a frequent trigger for panic states. Inadequate preparation — Someone who does not know what to expect — typical phase patterns, duration of effects, possible perceptual changes — more frequently experiences the onset of effects as a loss of control rather than as a process. Risky substance combinations — Alcohol combined with classical psychedelics increases nausea and panic risk. Stimulants (amphetamines, cocaine) combined with psychedelics often produce aversive cardiovascular and psychological tension states. MAO inhibitors combined with tryptamines (especially 5-MeO-DMT) can produce life-threatening interactions (serotonin syndrome). Physical exhaustion — Sleep deprivation, dehydration, low blood sugar, and physical exhaustion demonstrably worsen resilience in the face of intense experiences. Negative expectations formed through media consumption — Repeated exposure to horror scenarios about drug use — without balanced information — can produce a self-fulfilling anticipatory anxiety that actually affects the trip negatively. Set: Establishing the Right Mental State Preparation (1–2 Weeks Before the Experience) Harm reduction organisations and research in the field of psychedelic-assisted therapy recommend structured preparation. This does not mean over-intellectualising the experience — but informed, reflective preparation is a measurable protective factor. Practical steps: Clarify intention: Why do I want this experience? A conscious intention is no guarantee of a smooth trip, but it provides an orienting thread for difficult moments Research the substance: Duration of effects, typical experience phases, risk profile, known contraindications — sources such as PsychonautWiki or drugcom.de (BZgA's drugcom.de — Germany's Federal Centre for Health Education online drug counselling service) offer factual information Emotional stocktaking: Are there acute conflicts, unresolved grief, ongoing stress? Psychedelics do not choose the topic — they amplify what is already there Managing expectations: The experience cannot be forced. A "I must have enlightenment" mentality creates pressure that can burden the experience Personality Factors and Contraindications Research into psychedelic-assisted therapy has clearly identified contraindications for classical psychedelics. Individuals with: Schizophrenia or other psychosis-spectrum disorders (or a corresponding family history) Bipolar disorder type I Active severe depressive episode without therapeutic support ...should only consider classical psychedelics after consulting with psychiatric and therapeutic professionals — if at all. This is not a moral judgement, but a risk assessment grounded in empirical evidence. Questions for self-assessment: How do I respond to loss of control in other areas of my life? Am I currently in a stable phase of life? Do I have experience with intense anxiety states or panic attacks? Setting: Consciously Shaping the Environment Physical Environment The ideal setting does not exist as an absolute category — it is the setting that feels safe and familiar to the individual in question. The following foundational principles have proven themselves in practice: Prefer familiar surroundings — Your own home, or that of a very trusted person, reduces the cognitive load associated with orienting oneself in unfamiliar spaces Ensure a retreat option — A room to withdraw to when stimuli become too much Practical preparation: Water and light snacks (fruit, nuts) within easy reach; blankets; cushions; dimmed, warm lighting; an eye mask if desired for introspective phases Reduce technology — Put the phone on silent; avoid social media; but leave an emergency contact number visible Safety check: Gas off? Doors secure? This brief check before beginning reduces the unconscious activation of the threat-detection system during the experience Social Setting: The Trip Sitter A trip sitter — a sober, trusted person who accompanies the full duration of the experience — is one of the strongest protective mechanisms against escalating bad trip experiences. Research in psychedelic-assisted therapy assigns guides and therapists a central role for good reason. What a good trip sitter brings: Personal experience with psychoactive states (not necessarily with the same substance, but an understanding of altered states of consciousness) Emotional stability and the capacity to remain calm even during agitated states Clear prior agreements: When do they intervene? What should be done if the person signals panic? When is emergency services called? Non-intrusiveness: The sitter is available, not constantly present. The person having the experience should know that someone is there — without being continually interrupted Acoustics and Music Music demonstrably exerts a strong influence on psychoactive experiences. The psilocybin research programme at Johns Hopkins University uses a scientifically compiled playlist that is publicly accessible (Open Science Framework) and oriented around emotional arc. The following have proven effective: Calming instrumental music without strong lyrical messages in the early phases Classical music or ambient during intense peaks Familiar, positively associated music when grounding is needed Avoid: Sudden volume changes, aggressive rhythms, lyrics with emotionally charged or burdensome content Substance-Specific Risk Profiles: An Overview Note: This table serves harm reduction purposes and does not constitute a recommendation to consume illegal substances. The pharmacological properties are scientifically documented; individual responses can vary considerably. Substance Bad trip risk Common triggers Duration of effects Harm reduction notes LSD / Lysergamides Medium–High High dose, poor setting, counterfeit material 8–14 h Reagent test; low starting dose; experienced sitter Psilocybin (mushrooms) Medium Mindset dominant; nausea at onset is common 4–6 h Sobriety before ingestion; familiar setting MDMA Low–Medium Overheating, dehydration, polydrug use, frequent use 3–5 h Cool environment, moderate water intake (hyponatraemia risk) Cannabis (high THC) Low–Medium First-time experiences, too high a dose, edibles Variable CBD products may theoretically act antagonistically Ketamine Low–Medium Dissociation at high doses, K-hole 45–90 min Never alone; no mobility during effects DMT / Ayahuasca High (intensity) Unexpected intensity of experience 10–20 min (DMT) / 4–6 h (Ayahuasca) Experienced ceremony facilitator; observe MAO inhibitor interactions Amanita muscaria Low Nausea, GABAergic mechanism differs from psilocybin 4–8 h Not a psilocybin-containing mushroom; hydration What to Do During a Bad Trip? Seven Proven SOS Techniques These techniques are based on recommendations from harm reduction organisations (eve-rave, mindzone, Zendo Project) as well as clinical protocols from psychedelic-assisted research: 1. Slow the Breath — Box Breathing Slow, controlled breathing demonstrably activates the parasympathetic nervous system via the vagus nerve and can alleviate an acute panic response within a few minutes. The technique: Inhale for 4 seconds → hold for 4 seconds → exhale for 4 seconds → hold for 4 seconds. Three to five cycles are often sufficient to measurably lower heart rate. It helps the sitter to demonstrate and join in the technique — non-verbal synchronisation has an additional calming effect. 2. Change the Environment A different room, fresh air, a different light atmosphere — even small changes in environment can interrupt the psychological spiral. The brain in an altered state of consciousness is highly reactive to sensory input: a new stimulus can pull attention out of an anxiety loop. Being outside in a safe garden or on a quiet balcony has proven particularly helpful in user reports. 3. Use a Familiar Voice The sitter should speak calmly and clearly — no philosophical commentary, no relativising of the experience, no "this isn't real." Instead: "I'm here. You are safe. This is the substance." Simple, concrete, repeatable sentences. With physical contact (holding a hand), always ask first — unexpected touch can be counterproductive. 4. Temporal Orientation and Substance Reminding One of the most destabilising aspects of intense psychoactive states is the loss of the sense of time and the conviction that the state could be permanent. The Zendo Project's sitter protocol explicitly recommends: "You took [substance]. The effects will last approximately X more hours. After that, you will feel like yourself again." This information — even if it seems hard to anchor in the moment — gives the person having the experience a framework. 5. Physical Grounding Sensory stimuli that remind one of the here and now can alleviate dissociation: cold water on the face and hands, ice cubes in the mouth (caution: swallowing reflex), the texture of a familiar blanket, standing barefoot on the floor. These techniques are borrowed from trauma therapy grounding and work on similar principles during altered states of consciousness. 6. Consciously Change the Music If the current playlist is reinforcing a negative experiential channel, a deliberate music change can initiate a shift. Familiar, positively associated pieces (favourite music from stable periods of life) or very calm instrumental pieces have proven helpful. The sitter can announce the change beforehand — this creates a new attentional focus. 7. Let Go Rather Than Fight — Surrender This is possibly the most effective and simultaneously the hardest technique to teach: resistance to the experience regularly intensifies it. Research data from Johns Hopkins and Imperial College London shows that the strongest correlation with negative experiences is fear of loss of control — and the attempt to regain control. Users who have learned to yield to the current of the experience (even when it is unpleasant) more frequently report a dissolution of anxiety. The sitter's role is to gently offer this invitation to let go — not to force it. Pharmacological Emergency Brakes: Trip Stoppers Overview ⚠️ This section serves to inform about emergency options — not to guide self-medication. Pharmacological interventions should, wherever possible, be carried out by qualified medical personnel. Benzodiazepines (e.g. Lorazepam, Diazepam) Benzodiazepines are considered in the clinical harm reduction literature and in psychedelic-assisted therapy research to be the most effective pharmacological option in an escalating psychedelic emergency. They substantially reduce the anxiolytic burden without necessarily bringing the entire experiential state to an abrupt end. Typical application in clinical contexts: lorazepam 1–2 mg orally or sublingually. Important: These medications require a prescription; in an emergency, emergency services (112) are the correct point of contact. ⚠️ Critical warning: The combination of benzodiazepines and alcohol is potentially life-threatening due to additive respiratory depression. Never combine. Antipsychotics (e.g. Olanzapine, Haloperidol) In very rare, clinically escalated cases (persistent psychosis-like states), antipsychotics may be indicated — exclusively by qualified medical personnel. First-generation antipsychotics (haloperidol) can be counterproductive with some substances and are less recommended in modern protocols than atypical antipsychotics. CBD (Cannabidiol) for Cannabis-Induced Anxiety Some research and user reports suggest that CBD may counteract the anxiety effects of high-dose THC, since CBD acts as a partial antagonist at the CB1 receptor. The evidence for this is limited and inconsistent — it represents a low-risk option, not a proven intervention. Niacin (Vitamin B3) — Myth or Method? Niacin circulates in some communities as a purported "LSD antidote." Pharmacologically, there is no convincing basis for this claim: niacin does not interact with the serotonergic system in any known way that would meaningfully antagonise LSD's effects. Drug-checking organisations and harm reduction resources do not recommend niacin as a trip stopper. Anecdotal reports exist, but their effects are most likely explained by placebo and the physical flush response. When to Call Emergency Services Immediately (112)? Loss of consciousness or extreme sedation Breathing difficulties, seizures Persistent disorientation with aggression potential and risk of self-harm Suicidal impulses or statements Strongly elevated body temperature (hyperthermia — particularly with MDMA combined with stimulants) Perceptual disturbances that persist after the full duration of effects (based on typical duration) has elapsed Germany: Emergency 112 | BZgA Drug Helpline: 0800 1 31 23 13 (free, anonymous, 24/7) Set & Setting for Microdosing Microdosing — the ingestion of sub-threshold doses of psychoactive substances (typically 1/10 to 1/20 of a fully perceptible dose) — has attracted considerable public and scientific interest in recent years. Studies suggest that while classic bad trip experiences do not occur at this dosage range, set & setting remain relevant for several reasons: Emotional amplification even at microdoses: Users report that existing emotional burdens become more noticeably perceptible under microdosing — not with the intensity of a full trip, but palpably so. Someone microdosing during an acute crisis may experience unexpected emotional amplification. Setting on working days: The popular Fadiman protocol (1 dose day, 2 off days) is designed for productive working days. Users recommend reducing demanding meetings, confrontations, or emotionally charged conversations on dose days wherever possible. Protocol selection: The Fadiman protocol and the Stamets protocol (4 days on, 3 days off) differ in frequency and intended effect. The research base is not yet sufficient to make evidence-based recommendations for either (cf. Szigeti et al., 2021, eLife). Tolerance build-up: Frequent ingestion of classical psychedelics leads to rapid tolerance build-up through downregulation of the 5-HT2A receptor. Observing rest periods is pharmacologically sensible. Drug testing even with small amounts: Adulterants are a risk factor regardless of dose. Substance testing applies to microdoses too. Integration: What Comes After a Difficult Experience The phase following an intense or challenging psychoactive experience — the integration phase — is considered just as important as preparation in harm reduction contexts and therapy research. Immediately after the experience (0–48 hours): Prioritise rest and physical recovery — no full working day, no social pressure Drink fluids, eat lightly, sleep Avoid premature judgements: experiences perceived directly after the trip are often distorted In the first weeks: Writing is a well-documented integration tool: write down the experience — don't analyse it, just describe it. Re-read after a week. Speak with a trusted person who will not be judgemental and who can listen well Art-making, movement, contact with nature — body-oriented forms of processing can help when language is insufficient Professional integration: The MIND Foundation Berlin (mind-foundation.org) offers integration workshops and can refer to therapists experienced in psychedelic processes. Demand for this type of support has noticeably increased in Germany in recent years, and available provision is growing accordingly. When to see a therapist? Persistent sleep disturbances lasting more than 1–2 weeks Persistent anxiety or panic attacks Social withdrawal and depression Symptoms that could indicate HPPD (Hallucinogen Persisting Perception Disorder): persistent visual shimmering, halos, visual afterimages When Is Professional Help Absolutely Necessary? The following list is not a complete medical indication list, but a pragmatic orientation guide: Suicidal thoughts or impulses toward self-harm — Emergency 112 or crisis helpline Persistent perceptual disturbances more than 24 hours after the effects of the consumed substance have ended (based on typical duration of effects) Acute psychosis-like symptoms — paranoia, delusions, hallucinations without any substance still active Seizures, loss of consciousness, hyperthermia Persistent panic attacks and severe anxiety disorder lasting more than 1–2 weeks Severe sleep disturbances lasting more than 2 weeks If you feel that you are no longer yourself — even without classic symptoms Points of contact in Germany: Emergency services: 112 BZgA Drug Helpline (Germany's Federal Centre for Health Education): 0800 1 31 23 13 (free, anonymous, 24/7) Telephone counselling (Telefonseelsorge): 0800 111 0 111 or 0800 111 0 222 (free, 24/7) Psychiatric emergency department at the nearest hospital Harm Reduction Resources for Germany and Switzerland These organisations provide evidence-based, non-judgemental educational work: Organisation Focus Link drugcom.de BZgA online drug counselling (Germany's Federal Centre for Health Education) — free, anonymous drugcom.de mindzone Harm reduction Bavaria / party drug support mindzone.info eve+rave Berlin Harm reduction in the party scene, drug checking eve-rave.net MIND Foundation Psychedelic research + integration, Berlin mind-foundation.org Saferparty.ch Drug checking + information, Zurich saferparty.ch checkit! Wien Drug checking programme, Austria checkit.wien PsychonautWiki Substance information database, community-maintained psychonautwiki.org Zendo Project Psychedelic harm reduction training zendoproject.org FAQ — 10 Frequently Asked Questions About Bad Trips and Set & Setting 1. What is a bad trip? A bad trip describes a psychoactive experience that is subjectively overwhelming, anxiety-laden, or disorienting. The term is not a medical diagnosis, but a community expression. Important to know: studies suggest that difficult experiences can, under certain conditions, be integratively valuable in the long term — though this does not make dealing with acute crises any easier. 2. How long does a bad trip last? This depends strongly on the substance consumed. A difficult psilocybin trip can last 4–6 hours; an LSD experience can last 8–14 hours. Intense phases within a trip rarely last the full duration of effects. Knowing the expected duration is one of the most important anchors when dealing with acute anxiety states. 3. How can I stop a bad trip? A complete "stop" button does not exist. Proven non-pharmacological techniques include box breathing, changing environment, physical grounding, and consciously releasing resistance. Pharmacologically, benzodiazepines (only via medical or emergency services) are considered the most effective option for reducing anxiety symptoms with classical psychedelics. 4. Does niacin (Vitamin B3) work against bad trips? Niacin circulates as a supposed LSD antidote in some communities. Pharmacologically, there is no convincing basis for this: niacin does not interact in any known way with the serotonergic mechanisms through which psychedelics act. Harm reduction organisations do not recommend niacin as a trip stopper. 5. When do I need to call an ambulance during a bad trip? Immediately in cases of: loss of consciousness, seizures, breathing difficulties, persistently high fever, suicidal impulses or statements, ongoing risk of harm to self or others. Emergency number: 112. 6. What is the difference between set and setting? "Set" (mindset) refers to the inner state of a person: their emotional condition, expectations, personality structure, and current life phase. "Setting" refers to the external environment: physical space, social companionship, safety, music. Together, both factors explain more variance in the outcome of a psychoactive experience than the substance and dose themselves, according to research data. 7. Can a bad trip be positively integrated afterwards? Studies suggest yes. Carbonaro et al. (2016) report that people who experienced intense anxiety during a psilocybin experience frequently rated that experience in retrospect as meaningful — provided active integration takes place. Writing, conversation, professional support, and time are central factors. 8. Are microdoses protected from bad trips? Largely yes: microdoses (1/10 to 1/20 of an active dose) generally do not produce fully perceptible intoxicated states. Nevertheless, users report emotional amplification of existing states. Set & setting remain relevant factors even at small doses, especially during emotionally burdened periods of life. 9. What is HPPD and how common is it? HPPD (Hallucinogen Persisting Perception Disorder) refers to persistent visual perceptual disturbances (shimmering, halos, afterimages) following psychedelic use that persist even after the substance's effects have subsided. The exact prevalence is unknown; estimates vary considerably. Risk factors include frequent use, high doses, pre-existing visual disturbances, and concurrent cannabis use. If suspected, a neurologist or psychiatrist should be consulted. 10. Which substances carry the highest bad trip risk? Substances with long duration of effects, high dosage variability, and strong psychological potency — such as LSD/lysergamides and high-dose psilocybin — are considered higher risk for difficult experiences, especially with inadequate preparation. DMT and 5-MeO-DMT produce very intense, short experiences that can feel overwhelming without experience and an appropriate setting. MDMA and ketamine have a statistically lower, but by no means negligible, risk profile. Where amama Stands in This Educational Work amama is a Berlin-based smartshop for ethnobotanical products — including traditional botanicals such as kratom, blue lotus, rapé, and iboga products. We operate exclusively within the framework of German and European law and do not stock any substances subject to the BtMG (German Narcotics Act) or NpSG (New Psychoactive Substances Act). This educational page serves a clear purpose: we believe that informed people make better decisions. Not everyone who is interested in psychoactive experiences makes that decision out of addiction or a problem — many people consciously seek spiritual, creative, or therapeutic experiences. These people deserve good, honest, scientifically grounded information. We follow the principle of "informed exploration" — conscious, prepared exploration rather than blind consumption. This means: No glorification of psychoactive experiences No demonisation either Clear communication of risks, resources, and emergency options Education oriented toward the harm reduction movement, not toward sales targets If you have questions about our ethnobotanical products or the content of this page, you can reach us directly through our website. Related Guides on amama.space Iboga Guide — Ibogaine, the Bwiti tradition, risk profile and contraindications Blue Lotus Guide — Nuciferine, gentle effect profile, traditional use Rapé Guide — Set & setting in the Amazonian tradition, application, intention Kratom Guide — Mitragynine, vein colours, dosage profiles Legal Plants & Substances in Germany 2026 — Current legal status at a glance Last updated: May 2026. This article serves exclusively educational purposes and does not constitute medical advice or an encouragement to consume psychoactive substances. In emergencies: Emergency 112. BZgA Drug Helpline (Germany's Federal Centre for Health Education): 0800 1 31 23 13 (free, anonymous, 24/7).

Learn more

Legal Drugs in Germany: Complete Guide 2026

TL;DR — The short answer up front: "Legal drug" is not a uniform legal term in Germany — it describes anything that is neither prohibited under the Betäubungsmittelgesetz (BtMG) Narcotics Act nor under the Neue-psychoaktive-Stoffe-Gesetz (NpSG) Novel Psychoactive Substances Act. The term covers a broad spectrum — from everyday substances like caffeine and alcohol to ethnobotanical plants and novel lysergamide analogues. Here is what you need to know: "Legal" is multi-tiered: Freely available (alcohol, caffeine), pharmacy-only (codeine, modafinil), prescription-only (medical cannabis), or regulated outside BtMG/NpSG (ethnobotanicals, certain lysergamides). Most important legal psychoactive substance classes in 2026: Classic stimulants (caffeine, nicotine), ethnobotanicals (kratom, blue lotus, kanna, iboga, rapé, damiana, Salvia divinorum), cannabinoids (CBD, cannabis under the CanG Cannabis Act), lysergamide analogues (1cP-LSD, 1V-LSD, and others), fly agaric alkaloids (muscimol). What changed between 2024 and 2026: Cannabis was partially legalised under the Cannabisgesetz (CanG) Cannabis Act in April 2024; lysergamide analogues such as 1V-LSD were added to the NpSG in the interim, while new analogues (1FE-LSD, 1BP-LSD, and others) currently still fall outside the NpSG — the legal situation is dynamic. Who sells what: Pharmacies (pharmaceuticals), smartshops (ethnobotanicals, lysergamides), drugstores and supermarkets (alcohol, caffeine, tobacco). Where amama stands: amama.space is a Berlin-based smartshop with an ethnobotanical focus that exclusively offers products compliant with BtMG and NpSG, and places value on science-based education. Safety note: Legal does not mean risk-free. All psychoactive substances — including freely available ones — can cause harm when used improperly. Informed decisions protect. Not medical advice: This article is intended for educational purposes, not diagnosis or treatment recommendations. What Does "Legal Drug" Mean? The word "drug" is not a precisely defined term under German law. In everyday speech it refers to psychoactive substances — in pharmacy, however, "Droge" classically denotes dried plant material used for medicinal purposes (e.g. chamomile flowers). For the legal question, what matters is not the term itself but whether a substance is listed in the relevant legislation. In Germany, the legality of psychoactive substances falls into four tiers: 1. Freely Available Substances obtainable without any restriction in supermarkets, kiosks, or online. These include alcohol (from age 16 or 18), tobacco and nicotine (from age 18), caffeine (in coffee, tea, energy drinks), sugar, and various herbal teas and dietary supplements. These substances are psychoactive — but so socially normalised that their nature as drugs is often not perceived. 2. Pharmacy-Only (Without Prescription) Certain substances with psychoactive potential are available exclusively in pharmacies, but without a doctor's prescription: diphenhydramine (sleep aids), low-dose codeine (in cough syrups), dextromethorphan (DXM, in cough preparations), and — depending on dosage — phenibut in some dietary supplements. 3. Prescription-Only These substances require a doctor's prescription. They are legal but accessible only under medical supervision: modafinil, methylphenidate (Ritalin), opioids such as buprenorphine or methadone, and — since the 2024 cannabis reform — THC-containing cannabis flowers on prescription. 4. Regulated Outside BtMG and NpSG This category is the most relevant for smartshops and those interested in ethnobotany. Substances and plants that are listed neither in the BtMG (Schedules I–III) nor in the NpSG occupy a legal space — albeit one that can change quickly. Currently included are: kratom, blue lotus, iboga (the plant), rapé, kanna, damiana, Salvia divinorum (not yet prohibited in Germany), Amanita muscaria (fly agaric / muscimol), and various lysergamide analogues such as 1cP-LSD, 1FE-LSD, and 1BP-LSD. What is illegal? BtMG Schedule I lists non-trafficable narcotics: LSD (lysergic acid diethylamide), MDMA, psilocybin, psilocin, DMT, mescaline, heroin, cocaine, and many others. Schedule II covers trafficable but non-prescribable substances; Schedule III covers prescribable narcotics. The NpSG (in force since 2016) captures entire substance classes — for example certain synthetic cannabinoids, cathinones, and lysergamides — thereby making not just individual substances but whole groups of compounds illegal. Overview Table: What Is Legal in Germany in 2026? Substance Category Status in Germany 2026 Available at amama Caffeine Stimulant Freely available No (not a focus) Nicotine / Tobacco Stimulant Freely available (18+) No Alcohol (Ethanol) Sedative Freely available (16/18+) No Kratom (Mitragyna speciosa) Ethnobotanical Legal, not in BtMG/NpSG Yes Blue Lotus (Nymphaea caerulea) Ethnobotanical Legal Yes Iboga (Tabernanthe iboga, plant) Ethnobotanical Legal (ibogaine is in BtMG) Yes Rapé (Hapé) Ethnobotanical Legal Yes Kanna (Sceletium tortuosum) Ethnobotanical Legal Yes Damiana (Turnera diffusa) Ethnobotanical Legal Yes Salvia divinorum Ethnobotanical Legal (not yet listed) Yes Amanita muscaria (Fly Agaric) Fungi Legal (muscimol not in BtMG) Yes CBD (Cannabidiol) Cannabinoid Legal (<0.2% THC) No (not a focus) Cannabis (recreational, CanG) Cannabinoid Partially legalised since April 2024 No HHC Cannabinoid derivative Legal grey zone No THCP / THCH Cannabinoid derivative Grey zone, shifting across Europe No 1cP-LSD Lysergamide analogue Legal (not in NpSG, as of 2026) Yes 1FE-LSD Lysergamide analogue Legal (not in NpSG, as of 2026) Yes 1BP-LSD Lysergamide analogue Legal (not in NpSG, as of 2026) Yes 1S-LSD Lysergamide analogue Legal (not in NpSG, as of 2026) Yes 1T-LSD Lysergamide analogue Legal (not in NpSG, as of 2026) Yes 1D-AL-LAD Lysergamide analogue Legal (not in NpSG, as of 2026) Yes 1V-LSD Lysergamide analogue In NpSG since 2022 — illegal No LSD (classic) Psychedelic BtMG Schedule I — illegal No MDMA Entactogen BtMG Schedule I — illegal No Psilocybin / Magic Mushrooms Psychedelic BtMG Schedule I — illegal No DMT Psychedelic BtMG Schedule I — illegal No Mescaline Psychedelic BtMG Schedule I — illegal No Cocaine Stimulant BtMG Schedule I — illegal No Heroin Opioid BtMG Schedule I — illegal No Khat (Catha edulis) Stimulant BtMG Schedule I — illegal in Germany No Phenibut Anxiolytic Grey zone (dietary supplement in Germany) No Nitrous Oxide (N₂O) Dissociative Legal as food additive; recreational use regulated No Poppers (Alkyl Nitrites) Vasodilator Legal (not as a medicine) No Note: This table reflects the state of knowledge as of April 2026. The NpSG empowers the federal government to prohibit new substance classes by statutory order without parliamentary debate. Changes can occur at short notice. Always verify the current legal situation before purchasing. Detailed Categories 1. Botanical Ethnobotanicals Ethnobotany is the science of traditional relationships between humans and plants. The following plants have been used for centuries or millennia in their cultures of origin and are currently legally available in Germany — provided they are not advertised as medicines. #### Kratom (Mitragyna speciosa) Kratom is a tree from South-East Asia (Thailand, Malaysia, Indonesia) whose leaves contain the alkaloids mitragynine and 7-hydroxymitragynine. At low doses kratom acts as a stimulant; at higher doses it is sedating and analgesic. Kratom is not listed in Germany's BtMG or NpSG and is therefore legally available — a status being monitored by authorities. Traditionally, field workers in South-East Asia chew kratom leaves to combat fatigue. In Western markets it is sold primarily as a powder or in capsules. Interactions with opioids and other substances are documented; cautious dosing is strongly recommended. amama carries curated kratom products; detailed information can be found in the Kratom Guide. #### Blue Lotus (Nymphaea caerulea) The blue lotus — also known as the blue water lily — is one of the oldest ritually used plants in the world and was deeply embedded in the religious and festive practices of ancient Egypt. The primary active compounds apomorphine and nuciferine have dopaminergic and mildly serotonergic properties. Subjectively described effects include mild relaxation, a slightly euphoric mood, and sedating qualities — without hallucinogenic potential at usual quantities. From a legal standpoint, blue lotus is entirely unproblematic in Germany. Find out more in the Blue Lotus Guide at amama. #### Iboga (Tabernanthe iboga) The iboga plant from Central Africa is the ceremonial plant of the Bwiti tradition in present-day Gabon and Cameroon. Its primary alkaloid ibogaine is listed in Germany's BtMG as a pure substance — however, the plant itself (bark, powder in non-isolated form) is not currently prohibited. This distinction is important: possession of ibogaine extract can be a criminal offence; possession of the plant root bark operates in a different legal space. Due to its intensity and cardiovascular risks, iboga is not a plant for the unprepared — prior medical assessment is strongly recommended. The Iboga Guide provides in-depth information. #### Rapé (Hapé) Rapé (pronounced "ha-PAY") is a ceremonial nasal snuff blend from the Amazon region, used in rituals by indigenous communities of Brazil and Peru for centuries. The base is typically mapacho (wild tobacco, Nicotiana rustica), mixed with wood ash residues and other plants. The effect is strongly stimulating and grounding; the nicotine content is considerably higher than in consumer tobacco. Rapé is legal in Germany. amama carries selected rapé blends with transparent provenance; the Rapé Guide explains tradition, application, and safety information. #### Kanna (Sceletium tortuosum) Kanna is a South African succulent traditionally used by the Khoisan peoples as a mood enhancer and anxiolytic. The active alkaloids mesembrenone and mesembrine inhibit serotonin reuptake (SSRI-like mechanism) and additionally act as PDE4 inhibitors. Kanna is considered a mildly psychoactive plant — discreet, well tolerated, but with clinically relevant interactions with other serotonergic substances and antidepressants. Kanna is not listed in Germany and is legally available. #### Damiana (Turnera diffusa) Damiana is a shrub from Mexico and Central America with a long tradition as an aphrodisiac and mood enhancer. Its phytochemical composition is complex; scientific evidence for pronounced psychoactive effects in humans is limited. Damiana is commonly consumed as a tea or extract and is completely legal in Germany. #### Salvia divinorum Salvia divinorum is a Mexican mint from the Sierra Mazateca, where it is used by Mazatec shamans in healing rituals. The primary active compound salvinorin A is the most potent naturally occurring kappa-opioid receptor agonist and produces intense, short-lived dissociative experiences. In Germany, Salvia divinorum is not yet listed in the BtMG or NpSG — in contrast to countries such as the USA (prohibited in many states), the United Kingdom, or Australia. This plant has considerable psychedelic potential; unprepared or uncontrolled use carries real risks. 2. Cannabis & Cannabinoids #### Partial Legalisation of Cannabis (CanG, since April 2024) The Cannabisgesetz (CanG) Cannabis Act came into force in April 2024 and marks a historic turning point in German drug policy. Adults aged 18 and over may now: carry up to 25 g of cannabis in public, possess up to 50 g (home-grown cannabis) at home, cultivate up to 3 cannabis plants for personal use, become members of licensed Cannabis Social Clubs and obtain cannabis there. Commercial retail sales are not yet open to all — pilot schemes are in planning. Medical cannabis on prescription continues to be available through pharmacies (approved since 2017, further facilitated in 2024). #### CBD (Cannabidiol) CBD is the non-psychoactive primary cannabinoid of the hemp plant. Products containing less than 0.2% THC are legal in Germany as dietary supplements, cosmetics, or hemp products. CBD itself has no intoxicating effect but shows anxiolytic and anti-inflammatory properties in studies. #### HHC, THCP, THCH Hexahydrocannabinol (HHC) and related derivatives are in a European regulatory grey zone. They are currently not listed in Germany's NpSG, but some EU countries have already introduced national prohibitions. amama does not carry these substances; anyone interested in their legal status should consult up-to-date sources. 3. Lysergamides — 1cP-LSD, 1V-LSD, 1FE-LSD, and Others Lysergamides are a class of psychedelic substances structurally related to lysergic acid — the core scaffold of classic LSD. Classic LSD (lysergic acid diethylamide) has been listed in Germany's BtMG Schedule I for decades and is therefore illegal. In recent years chemists have developed structural analogues that differ through acyl groups on the nitrogen and resemble LSD in their effects without falling under the BtMG. The NpSG has captured some of these substances — for example 1V-LSD (since 2022) — while others currently still fall outside the law. Currently not listed in the NpSG (as of April 2026): 1cP-LSD (1-cyclopropanoyl-LSD) — one of the best-known and longest legally available compounds in Germany 1S-LSD (1-propanoyl-LSD) 1T-LSD (1-tert-butanoyl-LSD) 1FE-LSD (1-(2-fluoroethanoyl)-LSD) 1BP-LSD (1-butyryl-LSD) 1D-AL-LAD The research community discusses these substances as "prodrugs" of LSD — meaning they may be metabolised in the body into LSD. The legal situation is based on the wording of the NpSG, which defines substance classes. Whether a specific new compound falls under an existing NpSG class can be legally complex and should, if in doubt, be assessed by legal experts. ⚠️ Important note: The NpSG empowers the federal government to list new substances by statutory order — without parliamentary debate. The legal status of individual lysergamide analogues can change at very short notice. Always check the current situation before making any decisions. A detailed chronicle of lysergamide regulation in Germany can be found in the article Chronicle of LSD Analogues at amama. The complete lysergamide collection is available at Lysergamides at amama. 4. Fungi and Fungal Compounds #### Psilocybin / Magic Mushrooms — Illegal Psilocybin and psilocin — the active compounds in so-called magic mushrooms — are listed in Germany's BtMG Schedule I. Possession, trafficking, and cultivation are criminal offences. In research, psilocybin is showing promising results for treatment-resistant depression (including studies from Imperial College London and Johns Hopkins), but has not yet been approved as a therapeutic option in Germany. #### Amanita muscaria (Fly Agaric) — Legal The fly agaric (Amanita muscaria) contains the active compounds muscimol and ibotenic acid. Muscimol is a potent GABA-A receptor agonist and produces sedating, dissociative, and dream-like states — biochemically completely different from psilocybin. Muscimol is not listed in Germany's BtMG or NpSG. Dried fly agaric, extracts, and muscimol preparations are legally available. Detailed information is provided in the Muscimol Compound Profile on amama. Safety note: Ibotenic acid (a precursor to muscimol) is neurotoxic and is present in raw fly agaric. Proper preparation (drying at low temperatures, optionally decarboxylation) reduces ibotenic acid in favour of muscimol. 5. Synthetic Substances / "Legal Highs" The term "legal highs" refers to synthetic psychoactive substances developed to circumvent prohibitions. Until 2016, Germany saw a flood of such products — synthetic cannabinoids ("spice"), cathinones ("bath salts"), NBOMe compounds, and others. The NpSG, which came into force in November 2016, largely ended this market in Germany. Rather than prohibiting individual substances, it bans substance classes — an approach that makes deliberate "evasion" through minor molecular modifications considerably harder. In this respect the NpSG differs fundamentally from the BtMG's principle of listing individual substances. There is currently no legal market for synthetic "legal highs" in the traditional sense in Germany. Lysergamide analogues and certain ethnobotanicals now fill the role that "legal highs" once played — albeit with different safety profiles and cultural contexts. 6. Pharmaceutical "Legal Drugs" Pharmacies are the most frequently overlooked source of legally obtainable psychoactive substances: Codeine (OTC cough syrups at low dosages): Mildly opioid, susceptible to misuse Diphenhydramine (OTC sleep aids): Antihistamine with sedating effect, deliriant at high doses Dextromethorphan (DXM) (in cough preparations): Dissociative at high doses (NMDA antagonist), structurally related to ketamine Modafinil: Prescription-only; wakefulness-promoting effect, well known among students Phenibut: GABA-B agonist; approved as a medicine in Russia, available in Germany as a dietary supplement in a grey zone; dependence potential is clinically established Not to be overlooked: alcohol (~3 million people dependent on alcohol in Germany), nicotine, and caffeine are the most societally significant legal drugs — pharmacologically active substances with tolerance, dependence, and withdrawal potential. "Buying Legal Drugs" — Where to Buy, What to Consider Overview of Purchase Locations Pharmacy: For all prescription and pharmacy-only substances. Expert advice, legally regulated quality. A doctor's prescription is mandatory for prescription-only substances. Smartshop: Specialist shops for ethnobotanicals, herbs, fungi, and (in certain countries) mushroom truffles or lysergamides. In Germany, a smartshop like amama.space specialises in legal products that are compliant with BtMG and NpSG. Reputable smartshops place value on transparent provenance, laboratory analyses, and factual information. Online retail: The most convenient route for many ethnobotanicals and lysergamides. Important: only buy from suppliers that offer independent lab tests (CoA — Certificate of Analysis), transparent provenance information, and clear legal classification. Drugstore / supermarket: Alcohol, tobacco, caffeine, and (low-dose) CBD products are available here. What Sets Reputable Suppliers Apart Lab tests (CoA): Every product should be tested for purity and constituents by an independent laboratory. Legal transparency: The supplier communicates clearly why a substance is legal and updates this assessment when laws change. No health claims: Legal products in Germany may not be marketed as medicines. Anyone promising miracle cures is acting not only dishonestly but potentially illegally. Age verification: Reputable suppliers restrict access to adults (18+). Education-oriented: Good suppliers provide information that enables informed decisions — as you are seeing right now. COLLECTION-GRID: lysergamide COLLECTION-GRID: rape Country Comparison: Which Drugs Are Legal Where? Germany Netherlands Czech Republic Portugal Switzerland USA (federal) Cannabis (recreational) Partially legalised (CanG 2024) Tolerated (coffeeshops), not legal Decriminalised (up to 15 g) Decriminalised Varies by canton Illegal (federal); many states legal Psilocybin Illegal (BtMG I) Illegal; truffles tolerated Decriminalised Decriminalised Clinical trials Illegal (federal); Oregon, Colorado: regulated Magic Truffles Illegal Legal, freely available — — — — MDMA therapy No approval No approval — — Permitted in clinical trials Phase 3 trials (FDA process stalled) Lysergamide analogues (e.g. 1cP-LSD) Legal (not in NpSG, as of 2026) Grey zone Grey zone Grey zone Grey zone Grey zone (Federal Analogue Act) Khat Illegal (BtMG I) Illegal Illegal Decriminalised Illegal Illegal Classic LSD Illegal (BtMG I) Illegal Decriminalised Decriminalised Illegal Illegal "Which Country Has All Drugs Legal?" This question appears regularly in search engines. The honest answer: no country in the world has fully legalised all drugs. Even the most liberal jurisdictions regulate psychoactive substances in one way or another. What differs is the degree and form of regulation: Portugal is the most frequently cited example: since 2001, possession of all drugs for personal use in small quantities has been decriminalised — meaning no criminal prosecution, but drugs remain illegal. Instead, a dissuasion system with counselling services applies. Trafficking and production remain criminal offences. Portugal is regarded as a model for evidence-based drug policy. Czech Republic (Prague): Personal use of small quantities of various substances is decriminalised. Prague has a reputation as a tolerant drug tourism destination — de jure, possession of small amounts is a misdemeanour; de facto, prosecution is rare. Buying and selling remain illegal. Netherlands: The "gedoogbeleid" (tolerance policy) permits the purchase of cannabis in coffeeshops and the sale of magic truffles (containing psilocybin) in "smartshops" — formally still not legal, but tolerated. This is not legalisation but pragmatic tolerance. Oregon and Colorado (USA): Oregon legalised psilocybin-assisted therapy in 2020 (Measure 109), Colorado in 2022 (Proposition 122). These reforms are limited and regulated — not a free market, but licensed therapeutic contexts. "Drugs Legal and Illegal" — The Grey Zone Substances Between clearly legal and clearly illegal there exist substances whose status is unclear, in flux, or interpreted differently from one authority to the next: HHC, THCP, THCH: Cannabinoid derivatives that do not fall under the BtMG but are on the European regulatory radar. Some EU countries have already introduced prohibitions. Salvia divinorum: Not yet prohibited in Germany, but increasingly regulated internationally. Phenibut: A medicine in Russia, available in Germany as a dietary supplement — with clinically relevant dependence potential. Khat (Catha edulis): Listed in Germany's BtMG Schedule I (cathinone as active substance), but culturally established and locally legal in some countries (e.g. Yemen, Ethiopia). Nitrous oxide (dinitrogen monoxide): Legal as a food additive; recreational use increasingly regulated (prohibited in some EU countries). No specific anti-consumption regulation in Germany yet. Poppers (alkyl nitrites): Legal as room aromas or cleaning agents; known as a sex drug; no prescription required, but not approved as a medicine. Next-generation lysergamide analogues: With each NpSG extension, new analogues emerge — the grey zone continuously shifts. Iboga extracts: The plant is legal; ibogaine as a pure substance is in the BtMG. Where does "extract" begin? Legally unclear. Headshop blends: Many products labelled as "bath salts", "air fresheners", or "herbal blends" contain prohibited substances — purchasing is risky and often a criminal offence. The word "drug" itself: Legally imprecise. Medically, colloquially, and legally, "drug" means different things — contributing to considerable societal confusion. Safety & Education ⚠️ Important: Legal does not mean safe. Alcohol is one of the most dangerous psychoactive substances in the world — not because of illegality, but because of availability, dosage, and social normalisation. Nicotine dependence is one of the most persistent addictive disorders. Kratom has real dependence potential with regular use. Even coffee can cause cardiac arrhythmias with excessive consumption. Principles for safe use of psychoactive substances (legal and illegal alike): Set & setting: State of mind and environment are decisive for the outcome of psychedelic experiences (a concept introduced by Timothy Leary, now clinically established). Dosage: Start with the lowest effective dose. Many problems arise from overdosing, not from the substance itself. Contraindications: Heart conditions, liver or kidney problems, and pre-existing psychiatric conditions (particularly psychosis or bipolar disorder) can significantly increase risk. Interactions: Particularly critical are MAO inhibitors (MAOIs) — classic antidepressants, moclobemide, and also herbal ones such as passionflower. Combining these with kratom, kanna, ayahuasca, or psychedelics can lead to life-threatening reactions (serotonin syndrome, hypertensive crisis). Pregnancy and breastfeeding: No psychoactive substance should be taken during pregnancy without medical consultation. No mixing: Polydrug use increases risks disproportionately. Information resources: drugcom.de (BZgA — Federal Centre for Health Education) mindzone.info (Harm Reduction Bavaria) Erowid.org (international substance database, English) EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) Drug checking services offered by local drug support organisations (Berlin: Release, Fixpunkt, and others) FAQ — 12 Common Questions 1. Which drugs are legal in Germany? Legally "legal" are all psychoactive substances not listed in the BtMG (Schedules I–III) or the NpSG. These include alcohol, nicotine, caffeine, many ethnobotanicals (kratom, kanna, blue lotus), certain lysergamide analogues (1cP-LSD and others), and muscimol (fly agaric). The complete list is not static — the law changes. 2. Are legal drugs safe? No — legal does not mean safe. Alcohol, for example, is legal and causes tens of thousands of deaths in Germany every year. Kratom, kanna, and lysergamide analogues also carry risks. Informed, cautious use is essential with any psychoactive substance. 3. Where can I buy legal drugs? Depending on the substance: in pharmacies (pharmaceuticals), supermarkets (alcohol, caffeine), smartshops (ethnobotanicals, lysergamides), or online from reputable retailers with verified lab tests and clear legal documentation. amama.space is one example of a specialised Berlin-based smartshop. 4. Are all ethnobotanical plants legal? Not necessarily. Most classic ethnobotanicals (kratom, kanna, blue lotus, rapé) are currently legal in Germany. However, some plants contain active compounds that are listed in the BtMG (e.g. peyote contains mescaline, ephedra contains ephedrine). Always check the plant and the active compound separately. 5. Is kratom legal in Germany? Yes. Kratom (Mitragyna speciosa) is listed neither in Germany's BtMG nor in the NpSG and is therefore legally purchasable. The situation is being monitored by authorities and could change — as of April 2026, however, kratom is legal. 6. What is the difference between the BtMG and the NpSG? The BtMG (Betäubungsmittelgesetz — Narcotics Act) lists specific individual substances and regulates their handling. The NpSG (Neue-Psychoaktive-Stoffe-Gesetz — Novel Psychoactive Substances Act, in force since 2016) covers entire substance classes and can be extended by statutory order — without a parliamentary vote. The NpSG was created to make deliberate molecular "evasion" more difficult. 7. Are lysergamides like 1cP-LSD really legal? As far as is known, yes — as of April 2026, 1cP-LSD is not listed in the NpSG or BtMG. However, the legal grey zone is real: an authority could argue that the prodrug concept (metabolism into BtMG-listed substances) is relevant. Prudent consumers and retailers continuously monitor the legal situation. 8. Are legal drugs from the Netherlands allowed in Germany? Not automatically. Magic truffles are tolerated in the Netherlands and contain psilocybin — which is a BtMG Schedule I substance in Germany. Importing them into Germany would be a criminal offence. Each country has its own laws; what is legal there can be illegal here. 9. What is a "designer drug"? "Designer drugs" are synthetically produced substances developed to circumvent prohibitions — through minimal molecular modifications of known substances. The NpSG was created in Germany to counter this phenomenon. The term is not legally precise. 10. Are "legal highs" still available? In the classic sense (synthetic cannabinoids, cathinones as "bath salts") — no. The NpSG largely ended that market in 2016. What is available in smartshops today are ethnobotanicals and lysergamide analogues, with a different legal and safety profile. 11. How do I tell reputable suppliers from dubious ones? Reputable suppliers offer: independent laboratory analyses (CoA), transparent provenance information, factual product descriptions without health claims, clear age verification, and legal classification of their products. Dubious suppliers sell substances labelled "not for human consumption" without any safety information — a red flag. 12. Does the legal situation change frequently? Yes. The NpSG allows the federal government to list substance classes by statutory order. Lysergamide analogues have been listed in Germany multiple times (e.g. 1V-LSD in 2022). Cannabis was partially legalised in 2024. The EU monitors the novel substances market. Anyone working with these substances should regularly check up-to-date sources. What amama Offers amama.space is a Berlin-based smartshop with an ethnobotanical focus, operating both online and with a Berlin retail location. The range exclusively covers substances and products that are legal under current German law (BtMG, NpSG). What sets amama apart: Compliance focus: All products are checked against the current legal situation. When laws change, the range is adjusted immediately. Science-based education: Extensive blog content (pillar articles, substance profiles, plant guides) provides evidence-based information without sales pressure. Curated selection: Not a mass market — carefully chosen products with transparent provenance and laboratory verification. Ethnobotanical context: amama understands plants and substances within their cultural and traditional context — not purely as a commercial interest. Key collections at amama: Lysergamides — 1cP-LSD, 1FE-LSD, 1BP-LSD, 1S-LSD, and others Rapé / Hapé — ceremonial mapacho blends Ethnobotanical plants (kratom, kanna, blue lotus, iboga, damiana) Fungi (fly agaric / Amanita muscaria) amama deliberately positions itself not as a "dealer" or "drug delivery service" but as an information and procurement resource for conscious adults who wish to engage with psychoactive substances in an informed and self-responsible way. Sources & Further Reading Current BtMG schedules: Federal Ministry of Health — BtMG BfArM (Federal Institute for Drugs and Medical Devices): www.bfarm.de — responsible for narcotic approvals and classifications NpSG (Novel Psychoactive Substances Act): Laws on the Internet — NpSG drugcom.de: www.drugcom.de — BZgA education portal for young adults mindzone.info: www.mindzone.info — Harm Reduction Bavaria, safer-use information EMCDDA (European Monitoring Centre for Drugs and Drug Addiction): www.emcdda.europa.eu — European early-warning system, substance profiles Erowid: www.erowid.org — international substance database, experience reports, pharmacological data (English) Cannabis Act (CanG) 2024: Federal Law Gazette — CanG DHS (German Centre for Addiction Issues): www.dhs.de — addiction prevention and specialist information Last updated: April 2026. For educational purposes only. No sales pressure. No medical advice. All statements regarding the legal situation reflect the state of knowledge at the time of the last update and are subject to change. If in doubt, consult a lawyer specialising in narcotics law.

Learn more
Where can I buy Legal LSD in Berlin?

Where can I buy Legal LSD in Berlin?

Looking to buy legal LSD in Berlin? You’ve got a few great options in the city, each with its own vibe and advantages. Here’s a quick guide to help you choose the right spot. The Locations: amama.space – Berlin-Mitte – Linienstraße 158Located in the heart of Berlin-Mitte, this shop is perfect for those who enjoy the bustling city center. Open from 14:00-21:00, it’s ideal if you prefer an afternoon visit or a late-night trip to pick up your products. The location offers easy access to public transport and a wide array of nearby cafes and art galleries for a full day out. amama.space – Berlin-Neukölln – Weserstr. 191If you’re hanging out in Neukölln, our store on Weserstr. 191 is the perfect option. Open from 12:00-20:00, it’s convenient whether you’re planning a midday stop or an evening stroll. Neukölln’s laid-back vibe and creative energy make it a great place to explore after your purchase. legal-lsd – Boxhagener Str. 72, FriedrichshainAnother well-known shop in Berlin’s Friedrichshain district is located on Boxhagener Str. 72. Open from 11:00-19:00, it’s a great option if you’re in the area earlier in the day. Friedrichshain is known for its vibrant nightlife and artistic corners, so you can easily combine your visit with some exploration of this trendy district. No matter where you decide to go, Berlin has a variety of options for purchasing legal LSD, so you can find the one that fits your schedule and location best!

Learn more